In accordance with the transparency requirements of the recommendations for continuing medical education of the German Medical Association of April 24, 2015 (4th revised edition, April 24, 2015, update chapter 6 „Neutrality and Transparency“; December 10, 2020), the sponsorship funds of all sponsors are disclosed below.

In accordance with the guidelines of the FSA (Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.), the conditions and scope of support from member companies must be presented transparently to participants both when announcing and organizing the congress.

In accordance with the guidelines of the AKG (Arzneimittel und Kooperation im Gesundheitswesen e.V.), member companies must ensure that their support is disclosed by the organizer both when the congress is announced and when it is held. The publication of the type and scope of the overall support does not constitute an obligation for the AKG member companies and is voluntary.

The industry partners confirm that the support provided is not intended to influence sales transactions, in particular procurement processes/pricing, or the prescription behavior of medical participants and/or their affiliated institutions, and that there are no expectations in this regard.